Publication
CORALreef Lipids
DOI 10.1056/NEJMoa2511002
Randomized placebo-controlled Phase 3: крупное устойчивое снижение LDL-C; primary endpoint — lipid surrogate, не cardiovascular events.
No news refers to this card yet.
Scales
Identifiers
- DOI
- 10.1056/NEJMoa2511002
Original sources
Details
- Journal
- N Engl J Med
- Year
- 2026
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.